vs

Side-by-side financial comparison of ATN International, Inc. (ATNI) and CATALYST PHARMACEUTICALS, INC. (CPRX). Click either name above to swap in a different company.

ATN International, Inc. is the larger business by last-quarter revenue ($169.1M vs $152.6M, roughly 1.1× CATALYST PHARMACEUTICALS, INC.). CATALYST PHARMACEUTICALS, INC. runs the higher net margin — 34.5% vs -4.0%, a 38.6% gap on every dollar of revenue. On growth, CATALYST PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (7.6% vs 1.2%). CATALYST PHARMACEUTICALS, INC. produced more free cash flow last quarter ($44.9M vs $7.1M). Over the past eight quarters, CATALYST PHARMACEUTICALS, INC.'s revenue compounded faster (24.5% CAGR vs -1.1%).

ATN International, Inc. (ATN) formerly known as Atlantic Tele-Network, Inc., is a publicly traded telecommunications company that is headquartered in Beverly, Massachusetts. It operates digital wireless, wireline, and both terrestrial and submarine fiber optic networks, serving markets that are geographically separated and technically challenging, such as the plains, deserts, and mountainous areas of the United States.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

ATNI vs CPRX — Head-to-Head

Bigger by revenue
ATNI
ATNI
1.1× larger
ATNI
$169.1M
$152.6M
CPRX
Growing faster (revenue YoY)
CPRX
CPRX
+6.4% gap
CPRX
7.6%
1.2%
ATNI
Higher net margin
CPRX
CPRX
38.6% more per $
CPRX
34.5%
-4.0%
ATNI
More free cash flow
CPRX
CPRX
$37.7M more FCF
CPRX
$44.9M
$7.1M
ATNI
Faster 2-yr revenue CAGR
CPRX
CPRX
Annualised
CPRX
24.5%
-1.1%
ATNI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATNI
ATNI
CPRX
CPRX
Revenue
$169.1M
$152.6M
Net Profit
$-6.8M
$52.7M
Gross Margin
82.9%
Operating Margin
9.3%
40.5%
Net Margin
-4.0%
34.5%
Revenue YoY
1.2%
7.6%
Net Profit YoY
-261.7%
-5.8%
EPS (diluted)
$-0.31
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATNI
ATNI
CPRX
CPRX
Q4 25
$169.1M
$152.6M
Q3 25
$166.9M
$148.4M
Q2 25
$166.5M
$146.6M
Q1 25
$164.6M
$141.4M
Q4 24
$167.1M
$141.8M
Q3 24
$164.6M
$128.7M
Q2 24
$169.4M
$122.7M
Q1 24
$172.9M
$98.5M
Net Profit
ATNI
ATNI
CPRX
CPRX
Q4 25
$-6.8M
$52.7M
Q3 25
$3.9M
$52.8M
Q2 25
$-9.3M
$52.1M
Q1 25
$-11.4M
$56.7M
Q4 24
$4.2M
$55.9M
Q3 24
$-39.5M
$43.9M
Q2 24
$11.3M
$40.8M
Q1 24
$-7.9M
$23.3M
Gross Margin
ATNI
ATNI
CPRX
CPRX
Q4 25
82.9%
Q3 25
84.7%
Q2 25
85.9%
Q1 25
87.3%
Q4 24
84.7%
Q3 24
85.0%
Q2 24
87.4%
Q1 24
87.3%
Operating Margin
ATNI
ATNI
CPRX
CPRX
Q4 25
9.3%
40.5%
Q3 25
5.9%
44.7%
Q2 25
0.1%
45.2%
Q1 25
1.6%
44.8%
Q4 24
5.2%
44.3%
Q3 24
-23.3%
39.6%
Q2 24
14.4%
44.2%
Q1 24
2.6%
27.5%
Net Margin
ATNI
ATNI
CPRX
CPRX
Q4 25
-4.0%
34.5%
Q3 25
2.4%
35.6%
Q2 25
-5.6%
35.6%
Q1 25
-6.9%
40.1%
Q4 24
2.5%
39.4%
Q3 24
-24.0%
34.1%
Q2 24
6.7%
33.2%
Q1 24
-4.6%
23.6%
EPS (diluted)
ATNI
ATNI
CPRX
CPRX
Q4 25
$-0.31
$0.40
Q3 25
$0.18
$0.42
Q2 25
$-0.56
$0.41
Q1 25
$-0.69
$0.45
Q4 24
$0.16
$0.44
Q3 24
$-2.26
$0.35
Q2 24
$0.50
$0.33
Q1 24
$-0.50
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATNI
ATNI
CPRX
CPRX
Cash + ST InvestmentsLiquidity on hand
$102.9M
$709.2M
Total DebtLower is stronger
$565.2M
Stockholders' EquityBook value
$444.3M
$954.3M
Total Assets
$1.7B
$1.1B
Debt / EquityLower = less leverage
1.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATNI
ATNI
CPRX
CPRX
Q4 25
$102.9M
$709.2M
Q3 25
$106.6M
$689.9M
Q2 25
$99.4M
$652.8M
Q1 25
$83.8M
$580.7M
Q4 24
$73.7M
$517.6M
Q3 24
$101.0M
$442.3M
Q2 24
$59.2M
$375.7M
Q1 24
$56.8M
$310.4M
Total Debt
ATNI
ATNI
CPRX
CPRX
Q4 25
$565.2M
Q3 25
$579.6M
Q2 25
$583.4M
Q1 25
$562.4M
Q4 24
$557.4M
Q3 24
$568.9M
Q2 24
$540.8M
Q1 24
$541.3M
Stockholders' Equity
ATNI
ATNI
CPRX
CPRX
Q4 25
$444.3M
$954.3M
Q3 25
$452.3M
$920.2M
Q2 25
$458.7M
$856.0M
Q1 25
$473.3M
$794.3M
Q4 24
$489.5M
$727.6M
Q3 24
$490.8M
$660.9M
Q2 24
$526.8M
$608.7M
Q1 24
$530.0M
$561.4M
Total Assets
ATNI
ATNI
CPRX
CPRX
Q4 25
$1.7B
$1.1B
Q3 25
$1.7B
$1.1B
Q2 25
$1.7B
$971.9M
Q1 25
$1.7B
$908.9M
Q4 24
$1.7B
$851.4M
Q3 24
$1.8B
$772.0M
Q2 24
$1.8B
$706.4M
Q1 24
$1.8B
$646.7M
Debt / Equity
ATNI
ATNI
CPRX
CPRX
Q4 25
1.27×
Q3 25
1.28×
Q2 25
1.27×
Q1 25
1.19×
Q4 24
1.14×
Q3 24
1.16×
Q2 24
1.03×
Q1 24
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATNI
ATNI
CPRX
CPRX
Operating Cash FlowLast quarter
$36.2M
$44.9M
Free Cash FlowOCF − Capex
$7.1M
$44.9M
FCF MarginFCF / Revenue
4.2%
29.4%
Capex IntensityCapex / Revenue
17.2%
0.0%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$43.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATNI
ATNI
CPRX
CPRX
Q4 25
$36.2M
$44.9M
Q3 25
$37.8M
$32.4M
Q2 25
$23.9M
$71.3M
Q1 25
$35.9M
$60.0M
Q4 24
$30.5M
$70.9M
Q3 24
$39.0M
$72.9M
Q2 24
$35.2M
$64.1M
Q1 24
$23.2M
$31.9M
Free Cash Flow
ATNI
ATNI
CPRX
CPRX
Q4 25
$7.1M
$44.9M
Q3 25
$18.9M
Q2 25
$2.8M
$71.3M
Q1 25
$15.1M
Q4 24
$5.8M
$70.8M
Q3 24
$15.2M
$72.6M
Q2 24
$9.4M
$64.1M
Q1 24
$-12.8M
$31.7M
FCF Margin
ATNI
ATNI
CPRX
CPRX
Q4 25
4.2%
29.4%
Q3 25
11.3%
Q2 25
1.7%
48.6%
Q1 25
9.2%
Q4 24
3.5%
49.9%
Q3 24
9.2%
56.4%
Q2 24
5.6%
52.3%
Q1 24
-7.4%
32.2%
Capex Intensity
ATNI
ATNI
CPRX
CPRX
Q4 25
17.2%
0.0%
Q3 25
11.3%
0.0%
Q2 25
12.7%
0.0%
Q1 25
12.7%
0.0%
Q4 24
14.8%
0.1%
Q3 24
14.5%
0.2%
Q2 24
15.2%
0.0%
Q1 24
20.8%
0.2%
Cash Conversion
ATNI
ATNI
CPRX
CPRX
Q4 25
0.85×
Q3 25
9.62×
0.61×
Q2 25
1.37×
Q1 25
1.06×
Q4 24
7.24×
1.27×
Q3 24
1.66×
Q2 24
3.11×
1.57×
Q1 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATNI
ATNI

Us Telecommunications$86.9M51%
Fixed Consumer$42.8M25%
Fixed Business$18.5M11%
Transferred At Point In Time$7.2M4%
Mobility Business$5.3M3%
Other Revenue$4.2M2%
Other Communication Services$3.2M2%
Managed Services$1.2M1%
Construction Services$448.0K0%

CPRX
CPRX

Firdapse$97.6M64%
Agamree$35.3M23%
Fycompa$19.6M13%

Related Comparisons